These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 24219091)
1. Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery. Varshosaz J; Hassanzadeh F; Mardani A; Rostami M Pharm Dev Technol; 2015 Mar; 20(2):183-96. PubMed ID: 24219091 [TBL] [Abstract][Full Text] [Related]
2. Bovine serum albumin adsorbed PGA-co-PDL nanocarriers for vaccine delivery via dry powder inhalation. Kunda NK; Alfagih IM; Dennison SR; Tawfeek HM; Somavarapu S; Hutcheon GA; Saleem IY Pharm Res; 2015 Apr; 32(4):1341-53. PubMed ID: 25297713 [TBL] [Abstract][Full Text] [Related]
3. Preparation and optimization of doxorubicin-loaded albumin nanoparticles using response surface methodology. Li L; Zhao X; Yang C; Hu H; Qiao M; Chen D Drug Dev Ind Pharm; 2011 Oct; 37(10):1170-80. PubMed ID: 21449822 [TBL] [Abstract][Full Text] [Related]
4. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin. Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723 [TBL] [Abstract][Full Text] [Related]
5. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers. Li X; Vogt FG; Hayes D; Mansour HM J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451 [TBL] [Abstract][Full Text] [Related]
6. A multilayer hollow nanocarrier for pulmonary co-drug delivery of methotrexate and doxorubicin in the form of dry powder inhalation formulation. Nozohouri S; Salehi R; Ghanbarzadeh S; Adibkia K; Hamishehkar H Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():752-761. PubMed ID: 30889750 [TBL] [Abstract][Full Text] [Related]
7. Dry powder pulmonary delivery of cationic PGA-co-PDL nanoparticles with surface adsorbed model protein. Kunda NK; Alfagih IM; Dennison SR; Somavarapu S; Merchant Z; Hutcheon GA; Saleem IY Int J Pharm; 2015 Aug; 492(1-2):213-22. PubMed ID: 26169146 [TBL] [Abstract][Full Text] [Related]
9. Study on the Pulmonary Delivery System of Apigenin-Loaded Albumin Nanocarriers with Antioxidant Activity. Pápay ZE; Kósa A; Böddi B; Merchant Z; Saleem IY; Zariwala MG; Klebovich I; Somavarapu S; Antal I J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):274-288. PubMed ID: 28282259 [TBL] [Abstract][Full Text] [Related]
10. Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles. Azarmi S; Tao X; Chen H; Wang Z; Finlay WH; Löbenberg R; Roa WH Int J Pharm; 2006 Aug; 319(1-2):155-61. PubMed ID: 16713150 [TBL] [Abstract][Full Text] [Related]
11. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate. Simon A; Amaro MI; Cabral LM; Healy AM; de Sousa VP Int J Pharm; 2016 Mar; 501(1-2):124-38. PubMed ID: 26836711 [TBL] [Abstract][Full Text] [Related]
12. Effects of Chemical Conjugation of l-Leucine to Chitosan on Dispersibility and Controlled Release of Drug from a Nanoparticulate Dry Powder Inhaler Formulation. Muhsin MD; George G; Beagley K; Ferro V; Wang H; Islam N Mol Pharm; 2016 May; 13(5):1455-66. PubMed ID: 26998555 [TBL] [Abstract][Full Text] [Related]
13. Formulation development of albumin based theragnostic nanoparticles as a potential delivery system for tumor targeting. Kolluru LP; Rizvi SA; D'Souza M; D'Souza MJ J Drug Target; 2013 Jan; 21(1):77-86. PubMed ID: 23036042 [TBL] [Abstract][Full Text] [Related]
14. Budesonide dry powder for inhalation: effects of leucine and mannitol on the efficiency of delivery. Rattanupatam T; Srichana T Drug Deliv; 2014 Sep; 21(6):397-405. PubMed ID: 24401124 [TBL] [Abstract][Full Text] [Related]
15. Engineered bovine serum albumin-based nanoparticles with pH-sensitivity for doxorubicin delivery and controlled release. Yang Z; Zhang N; Ma T; Liu L; Zhao L; Xie H Drug Deliv; 2020 Dec; 27(1):1156-1164. PubMed ID: 32755291 [TBL] [Abstract][Full Text] [Related]
16. N-Acetyl-D-glucosamine decorated polymeric nanoparticles for targeted delivery of doxorubicin: Synthesis, characterization and in vitro evaluation. Tian B; Ding Y; Han J; Zhang J; Han Y; Han J Colloids Surf B Biointerfaces; 2015 Jun; 130():246-54. PubMed ID: 25921641 [TBL] [Abstract][Full Text] [Related]
17. Montelukast-loaded nanostructured lipid carriers: part II pulmonary drug delivery and in vitro-in vivo aerosol performance. Patil-Gadhe A; Kyadarkunte A; Patole M; Pokharkar V Eur J Pharm Biopharm; 2014 Sep; 88(1):169-77. PubMed ID: 25078860 [TBL] [Abstract][Full Text] [Related]
18. The development of dimple-shaped chitosan carrier for ethambutol dihydrochloride dry powder inhaler. Ahmad MI; Ungphaiboon S; Srichana T Drug Dev Ind Pharm; 2015 May; 41(5):791-800. PubMed ID: 24694185 [TBL] [Abstract][Full Text] [Related]
19. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base. Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421 [TBL] [Abstract][Full Text] [Related]
20. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery. Li X; Vogt FG; Hayes D; Mansour HM Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]